Emily H Castellanos (Emily Castellanos)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Venues

JCO clinical cancer informatics

JCO precision oncology

JCO oncology practice

Future oncology (London, England)

Flatiron Health

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Flatiron Health Aug 15 2018

United States

Associate Medical Director :: Research Oncology

Publications

Emily H Castellanos, Brett K Wittmershaus, Sheenu Chandwani
Raising the Bar for Real-World Data in Oncology: Approaches to Quality Across Multiple Dimensions. JCO clinical cancer informatics 8 (2024)
Emily H Castellanos, Brett K Wittmershaus, Sheenu Chandwani
Raising the Bar for Real-World Data in Oncology: Approaches to Quality Across Multiple Dimensions. JCO clinical cancer informatics 8 (2024)
Emily H Castellanos, Brett K Wittmershaus, Sheenu Chandwani
Raising the Bar for Real-World Data in Oncology: Approaches to Quality Across Multiple Dimensions. JCO clinical cancer informatics 8 (2024)
Emily H Castellanos, Brett K Wittmershaus, Sheenu Chandwani
Raising the Bar for Real-World Data in Oncology: Approaches to Quality Across Multiple Dimensions. JCO clinical cancer informatics 8 (2024)
Carsten Schröder, Craig Gower-Page, Irmarie Reyes-Rivera, Arisha Patel, Richard Price, Shiraj Sen, Jessica Davies, Emily H Castellanos, Jeremy Snider, Xiaobo Bai, Virginia A Fisher, Shivani K Mhatre
Natural History of Human Epidermal Growth Factor Receptor 2-Amplified and Human Epidermal Growth Factor Receptor 2 Wild-Type Refractory Metastatic Colorectal Cancer in US Clinical Practice. JCO clinical cancer informatics 6 (2022)
Daniel Backenroth, Jeremy Snider, Ronglai Shen, Venkatraman Seshan, Emily H Castellanos, Margaret McCusker, Dana Feuchtbaum, Mithat Gönen, Somnath Sarkar
Accounting for Delayed Entry in Analyses of Overall Survival in Clinico-Genomic Databases. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 31 (6) (2022)
Liangliang Zhang, Omar Hamdani, Ole V Gjoerup, Cheryl Cho-Phan, Jeremy Snider, Emily H Castellanos, Halla Nimeiri, Garrett M Frampton, Jeffrey M Venstrom, Geoffrey R Oxnard, Samuel J Klempner, Alexa B Schrock
ERBB2 Copy Number as a Quantitative Biomarker for Real-World Outcomes to Anti-Human Epidermal Growth Factor Receptor 2 Therapy in Advanced Gastroesophageal Adenocarcinoma. JCO precision oncology 6 (2022)
Stacey M Stein, Jeremy Snider, Siraj M Ali, Rebecca A Miksad, Brian M Alexander, Emily H Castellanos, Alexa B Schrock, Russell W Madison, Akshay Swaminathan, Jeffrey M Venstrom, Margaret McCusker
Real-world association of HER2/ERBB2 concordance with trastuzumab clinical benefit in advanced esophagogastric cancer. Future oncology (London, England) 17 (31) (2021)
Emily H Castellanos, Abigail Orlando, Xinran Ma, Ravi B Parikh, Gillian O'Connell, Neal J Meropol, H James Hamrick, Blythe J S Adamson
Evaluating the Impact of Oncology Care Model Reporting Requirements on Biomarker Testing and Treatment. JCO oncology practice 16 (10) (2020)
Emily H Castellanos, Mary S Dietrich, Stewart M Bond, Nancy Wells, Karen Schumacher, Apar Kishor Ganti, Barbara A Murphy
Impact of patient symptoms and caregiving tasks on psychological distress in caregivers for head and neck cancer (HNC). Psycho-oncology 28 (3) (2019)
Sayeh S Nikpay, Margaret G Tebbs, Emily H Castellanos
Patient Protection and Affordable Care Act Medicaid expansion and gains in health insurance coverage and access among cancer survivors. Cancer 124 (12) (2018)

Emily H Castellanos.css-eqlu8i{font-size:small;padding-left:4px;} (Emily Castellanos)

Publication Activity (10 Years)

Top Topics

Top Venues

Emily H Castellanos (Emily Castellanos)